Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/1995
07/05/1995EP0660821A1 Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
07/05/1995EP0660716A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
07/05/1995EP0660713A1 Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy
07/05/1995EP0660712A1 Transcutaneous in vivo activation of photosensitive agents in blood
07/05/1995EP0660711A1 Novel use of inhibitors of phosphodiestersase iv
07/05/1995EP0660707A1 Method of preventing nmda receptor-mediated neuronal damage
07/05/1995EP0660703A1 Topical carbonic anhydrase inhibitor composition
07/05/1995CN1104831A Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives
07/05/1995CN1104496A Internal radiation damage
07/05/1995CN1029230C Method for preparing of hydroxamic acid and N-hydroxyurea derivatives
07/05/1995CN1029227C Composition for denatured denaturation or protection agent for nerve cell and process for preparing benzene derivatives used for composition
07/04/1995US5430060 Aldose reductase inhibitor
07/04/1995US5430051 Photodynamic diagnosis and therapy of rheumatic diseases
07/04/1995US5430045 Administering an L-2-oxothiazolidine-4-carboxylate to patient receiving AZT
07/04/1995US5430031 Serotoninergic ergoline derivatives
07/04/1995US5430029 Pharmaceutical compositions active in the therapy of sleep disorders
07/04/1995US5430025 Elastase-inhibiting peptides bearing a C-terminal trifluoromethylketone moiety
07/04/1995CA2138000A1 Retinoid-like compounds
07/04/1995CA2137997A1 Retinoid-like compounds
07/04/1995CA1336192C Pharmaceutical benzoheterocyclylcarboxamide derivatives
07/04/1995CA1336191C Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
07/04/1995CA1336168C Method of preventing or treating toxemia in pregnancy using a thromboxane a_ receptor antagonist
07/04/1995CA1336166C Further improvements relating to drug delivery systems
07/01/1995CA2138929A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
07/01/1995CA2138877A1 Using a spin acceptor in a cosmetic or dermatological composition
07/01/1995CA2138875A1 Depigmentation composition for the simultaneous treatment of the superficial and deep layers of the skin, and its use
07/01/1995CA2138112A1 Water-in-oil emulsion containing retinol, its use and its conditioning
06/1995
06/29/1995WO1995017423A1 Compounds with growth hormone releasing properties
06/29/1995WO1995017422A1 Compounds with growth hormone releasing properties
06/29/1995WO1995017416A1 Dna encoding the wnt-x growth factor
06/29/1995WO1995017410A1 Heterocyclic compounds
06/29/1995WO1995017392A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor
06/29/1995WO1995017383A1 Indole derivatives as anti-estrogens
06/29/1995WO1995017382A1 Non-peptide tachykinin receptor antagonists
06/29/1995WO1995017379A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
06/29/1995WO1995017207A1 Parathyroid hormone formulation
06/29/1995WO1995017197A1 Vitamin d3 analogues and pathway to mediate disorders
06/29/1995WO1995017183A1 Use of pla2 inhibitors as treatment for alzheimer's disease
06/29/1995WO1995017182A1 Protein kinase c inhibitors
06/29/1995WO1995017180A1 A method of treating gastrointestinal motility disorders
06/29/1995WO1995017178A1 Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure
06/29/1995WO1995017170A1 Accelerated release composition containing bromocriptine
06/29/1995WO1995017095A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
06/29/1995WO1995017093A1 New cryptophycins
06/29/1995WO1995017092A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η?
06/29/1995WO1995011013A3 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women
06/29/1995DE4345266A1 New isoquinolone or phthalazinone carboxylic acid ester and derivs.
06/29/1995CA2187296A1 Indole derivatives as anti-estrogens
06/29/1995CA2179649A1 Use of pla2 inhibitors as treatment for alzheimer's disease
06/29/1995CA2179606A1 Macrophage inflammatory proteins-3, -4 and -1.gamma.
06/29/1995CA2179598A1 Compounds with growth hormone releasing properties
06/29/1995CA2179597A1 Compounds with growth hormone releasing properties
06/29/1995CA2179492A1 A method of treating gastrointestinal motility disorders
06/29/1995CA2179490A1 New cryptophycins
06/29/1995CA2179288A1 Vitamin d3 analogues and pathway to mediate disorders
06/29/1995CA2178833A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
06/29/1995CA2177851A1 Heterocyclic compounds
06/29/1995CA2177061A1 Dna encoding the wnt-x growth factor
06/29/1995CA2176130A1 Non-peptide tachykinin receptor antagonists
06/29/1995CA2176127A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
06/28/1995EP0659747A1 Branched aminothiazole derivatives process for their preparation and pharmaceutical compositions containing them
06/28/1995EP0659436A1 A potentiator for interferon and an antiviral activity-potentiating composition containing interferon and its potentiator
06/28/1995EP0659425A1 2-Phenyl-3-azoylbenzothiophenes for increasing macrophage function
06/28/1995EP0659421A1 2-Phenyl-3-azoylbenzothiophenes for treating menstrual symptoms
06/28/1995EP0659418A1 2-Phenyl-3-azoylbenzothiophene for treating Alzheimer's disease
06/28/1995EP0659414A2 Inhibition of hirsutism and alopecia in women
06/28/1995EP0659407A1 Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds
06/28/1995EP0659211A1 Methods and therapeutic compositions for treating cystic fibrosis
06/28/1995EP0659183A1 Heteroaryl compounds used as pharmaceuticals
06/28/1995EP0659179A1 Benzo-fused lactams promote release of growth hormone
06/28/1995EP0659174A1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
06/28/1995EP0659085A1 Method of inhibiting cell proliferation using apolipoprotein e
06/28/1995EP0659083A1 Prevention and treatment of peripheral neuropathy
06/28/1995EP0659082A1 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine
06/28/1995EP0659080A1 Method and composition for the treatment of hair loss
06/28/1995EP0521067B1 Azacyclic or azabicyclic compounds, their preparation and use
06/28/1995EP0494268B1 Method for inhibiting growth of stem cells
06/28/1995CN1104411A Ornithine decarboxylase inhibiting cyclic aminooxy compounds
06/28/1995CN1104209A 2,4-diamino-3-hydroxycarboxylic acid derivatives
06/28/1995CN1104091A Use of bisphosphonic acid derivatives for the preparation of drugs intended for promoting bone repair
06/28/1995CN1104090A Iron, cobalt, selenophene, copper, arsenic injection
06/27/1995US5428181 Treatment of bone disorders, osteoporosis
06/27/1995US5428158 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/27/1995US5428135 Production of platelet-derived growth factor B-chain heterodimers from high expression host cell system
06/27/1995US5428072 Method of increasing the efficiency of feed conversion in animals
06/27/1995US5428069 Treating cognition with, aminocyclopropanecarboxylic derivatives
06/27/1995US5428064 N-phenyl-amino-terminated non-peptidyl α-succinamidoacyl aminodiolsas anti-hypertensive agents
06/27/1995US5428054 Renin inhibitor
06/27/1995US5428051 Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
06/27/1995US5428044 Anti-inflammatory 4-aminophenyl derivatives
06/27/1995US5428033 Saturated hydroxyalkylquinoline acids as leukotriene antagonists
06/27/1995US5428021 Human leukocyte elastase (HLE) inhibitors, and related pharmaceutical compositions and methods of use
06/27/1995US5428019 Bombesin analogs
06/27/1995US5428018 Phenylalanine analogs of bombesin
06/27/1995US5427778 Gel formulations containing growth factors and acrylamide polymer
06/27/1995CA2088274C Calcium and trace mineral supplements
06/27/1995CA1336099C Urea based lipoxygenase compounds
06/27/1995CA1336066C Modulation of adenylate cyclase response
06/27/1995CA1336048C Process for making flexographic plates with increased flexibility
06/22/1995WO1995016702A1 Peptide inhibitors of cxc intercrine molecules
1 ... 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 ... 1564